Advanced Medicine Recall is written primarily for fourth year medical students, sub-interns, and interns. It expands upon the core clinical specialty areas within internal medicine—cardiology, pulmonology, nephrology, gastroenterology, hematology, oncology, infectious disease, endocrinology, allergy and immunology, rheumatology, neurology, and dermatology. This book is written in the rapid-fire question and answer format of the Recall Series, with the question on the left side of the page and the answer on the right. Mnemonics are interspersed throughout. Additional chapters in Advanced Medicine Recall include Environmental Medicine, Psychiatry, and The Consultant. The focus of the advanced material is on differential diagnosis, patient management, and disease management.
Now in its Sixth Edition, Surgical Recall allows for rapid-fire review of surgical clerkship material for third- or fourth-year medical students preparing for the USMLE and shelf exams. Written in a concise question-and-answer format—double-column, question on the left, answer on the right—Surgical Recall addresses both general surgery and surgical subspecialties. Students on rotation or being PIMPed can quickly refer to Surgical Recall for accurate and on-the-spot answers. The book includes survival tactics and tips for success on the boards and wards as well as key information for those new to the surgical suite.
Written primarily for third- and fourth-year medical students in clerkships, this new edition covers the core specialty areas within internal medicine, including cardiology, pulmonology, and oncology. Each chapter is written by faculty, students, and fellows and emphasizes diagnosis and treatment.
Advanced Surgical Recall, Third Edition is a quick review for the ABSITE and oral board exams in surgery. The book is written in rapid-fire question-and-answer format and contains detailed illustrations of anatomic landmarks and surgical techniques. This edition has seven new Microvignettes chapters that test recall via sample cases. These Microvignettes chapters include Clinical, Surgical Pathognomonic, Complications, Blood, Surgical Laboratory, Medical Treatment of Surgical Diagnoses, and Eponyms. Other new chapters include Advanced Procedures, Cell Biology and Cytokines, Wounds, Drains and Tubes, Surgical Respiratory Care, Renal Facts, Surgery by the Numbers and Surgical Formulae, Hand Surgery, Obstetrics and Gynecology, Diagnostic Surgical Stimulation and Radiographic Tests, and Power Review of Surgical Physiology.
Following its acclaimed predecessor Pediatrics Recall, this new Second Edition reviews disease entities to facilitate retention and mimic verbal testing covered in a pediatric clerkship. Its unique question-and-answer format is retained. This edition is organized by disease process and involved systems. The text includes descriptions, signs, symptoms, pathophysiology essentials, treatments and possible outcomes. New to this edition are some select figures. Topics cover basic issues in neonatal and pediatric fluid management, blood products, nutrition, growth, emergencies, and intensive care. One chapter is solely devoted to issues relating to the adolescent patient. Easy access design is ideal for clinical rotation usage.
Getting the right diagnosis is a key aspect of health care - it provides an explanation of a patient's health problem and informs subsequent health care decisions. The diagnostic process is a complex, collaborative activity that involves clinical reasoning and information gathering to determine a patient's health problem. According to Improving Diagnosis in Health Care, diagnostic errors-inaccurate or delayed diagnoses-persist throughout all settings of care and continue to harm an unacceptable number of patients. It is likely that most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences. Diagnostic errors may cause harm to patients by preventing or delaying appropriate treatment, providing unnecessary or harmful treatment, or resulting in psychological or financial repercussions. The committee concluded that improving the diagnostic process is not only possible, but also represents a moral, professional, and public health imperative. Improving Diagnosis in Health Care, a continuation of the landmark Institute of Medicine reports To Err Is Human (2000) and Crossing the Quality Chasm (2001), finds that diagnosis-and, in particular, the occurrence of diagnostic errorsâ€"has been largely unappreciated in efforts to improve the quality and safety of health care. Without a dedicated focus on improving diagnosis, diagnostic errors will likely worsen as the delivery of health care and the diagnostic process continue to increase in complexity. Just as the diagnostic process is a collaborative activity, improving diagnosis will require collaboration and a widespread commitment to change among health care professionals, health care organizations, patients and their families, researchers, and policy makers. The recommendations of Improving Diagnosis in Health Care contribute to the growing momentum for change in this crucial area of health care quality and safety.
During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was doneâ€"and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatmentâ€"Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referralâ€"including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated bloodâ€"analyzing decisions by federal agencies and the private sector. Risk communicationâ€"examining whether infections could have been averted by better communication of the risks.
Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Be ready to prescribe and administer drugs safely and effectively--and grasp all the vitals of pharmacology--with the fully updated Pharmacotherapeutics for Advanced Practice, 4th edition. Written by pharmacology nursing experts, this easy-to-read text offers proven frameworks for treating more than 50 common diseases and disorders. Learn how to identify disorders, review possible therapies, then prescribe and monitor drug treatment, accurately. Based on current evidence and real-life patient scenarios, this is the perfect pharmacology learning guide and on-the-spot clinical resource. Absorb the key principles and practical methods for accurate prescribing and monitoring, with . . . NEW chapter on Parkinson's disease, osteoarthritis, and rheumatoid arthritis NEWand updated therapies, and updated and additional case studies, with sample questions NEW content on the impacts of the Affordable Care Act Updated chapters on complementary and alternative medicine (CAM) and pharmacogenomics Updated evidence-basedalgorithms and drugtables - Listing uses, mechanisms, adverse effects, drug interactions, contraindications, and monitoring parameters, organized by drug class; quick access to generic and trade names and dosages Quick-scan format organizes information by body system Chapter features include: Brief overview - Pathophysiology of each disorder, and relevant classes of drugs Monitoring Patient Response section - What to monitor, and when Patient Education section - Includes information on CAM for each disorder Drug Overview tables - Usual dose, contraindications and side effects, and special considerations Algorithms - Visual cues on how to approach treatment Updated Recommended Order of Treatment tables - First-, second- and third-line drug therapies for each disorder Answers to Case Study Questions for each disorder - Strengthens critical thinking skills Selecting the Most Appropriate Agentsection - The thought process for choosing an initial drug therapy Principles of Therapeuticsunit - Avoiding medication errors; pharmacokinetics and pharmacodynamics; impact of drug interactions and adverse events; principles of pharmacotherapy for pediatrics, pregnancy/lactation, and geriatrics Disorders units - Pharmacotherapy for disorders in various body systems Pharmacotherapy in Health Promotion unit - Smoking cessation, immunizations, weight management Women's Health unit - Including contraception, menopause, and osteoporosis Integrative Approach to Patient Care unit - Issues to consider when presented with more than one diagnosis Standard pharmacotherapeutics text for nurse practitioners, students, and physician assistants Ancillaries - Case Study answers, multiple choice questions and answers for every chapter, PowerPoints, Acronyms List
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
